• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用吉诺生物工程R支架治疗的西欧和东南亚患者心血管危险因素及临床结局的差异:一项全球电子健康评估与学习网络注册研究的子研究

Differences in cardiovascular risk factors and clinical outcomes between Western European and Southeast Asian patients treated with the Genous Bio-engineered R stent: an e-HEALING worldwide registry substudy.

作者信息

Klomp Margo, Damman Peter, Beijk Marcel A M, Tan Kim H, Balian Vruyr, de Luca Giuseppe, Tijssen Jan G P, Silber S, de Winter Robbert J

机构信息

Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands.

出版信息

Coron Artery Dis. 2012 Jun;23(4):271-7. doi: 10.1097/MCA.0b013e328351aaed.

DOI:10.1097/MCA.0b013e328351aaed
PMID:22473083
Abstract

OBJECTIVE

Percutaneous coronary interventions (PCIs) are increasingly being performed worldwide to treat patients with coronary artery disease. However, studies on the influence of ethnicity on clinical outcomes after PCI are scarce. In our current analysis, we evaluate the differences in baseline clinical, angiographic and procedural characteristics, and 12-month clinical outcomes in patients undergoing nonurgent PCI in Western Europe and in Asia.

METHODS

We analyzed all patients enrolled in the worldwide e-HEALING (electronic Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry living in Western Europe and Asia. All patients were treated with at least one endothelial progenitor cell capturing stent. The main study outcome was target vessel failure at the 12-month follow-up, defined as the composite of cardiac death or myocardial infarction and target vessel revascularization.

RESULTS

A total of 3504 patients, 2873 living in Western Europe and 731 living in Asia, were assessed in the current analysis. Almost all of the baseline clinical and angiographic characteristics differed significantly between both populations. Target vessel failure at the 12-month follow-up occurred in 11.4% of the Western Europe patients and in 5.6% of the Asian patients (P<0.01).

CONCLUSION

We conclude that differences exist in the baseline, angiographic, and procedural characteristics between Western European and Asian patients undergoing nonurgent PCI. In addition, the 1-year clinical outcomes differ significantly after PCI between Western European and Asian patients. Our results indicate that reports from studies performed worldwide should include both overall and regional subgroup outcomes.

摘要

目的

在全球范围内,经皮冠状动脉介入治疗(PCI)越来越多地用于治疗冠状动脉疾病患者。然而,关于种族对PCI术后临床结局影响的研究较少。在我们当前的分析中,我们评估了西欧和亚洲接受非紧急PCI患者的基线临床、血管造影和手术特征以及12个月临床结局的差异。

方法

我们分析了全球e-HEALING(电子健康内皮加速内膜抑制新生内膜生长)注册研究中居住在西欧和亚洲的所有患者。所有患者均接受了至少一枚内皮祖细胞捕获支架治疗。主要研究结局是12个月随访时的靶血管失败,定义为心源性死亡或心肌梗死与靶血管血运重建的复合终点。

结果

在当前分析中,共评估了3504例患者,其中2873例居住在西欧,731例居住在亚洲。几乎所有基线临床和血管造影特征在两组人群中均有显著差异。12个月随访时,西欧患者的靶血管失败发生率为11.4%,亚洲患者为5.6%(P<0.01)。

结论

我们得出结论,西欧和亚洲接受非紧急PCI的患者在基线、血管造影和手术特征方面存在差异。此外,西欧和亚洲患者PCI术后1年的临床结局也有显著差异。我们的结果表明,全球范围内开展的研究报告应包括总体和区域亚组结局。

相似文献

1
Differences in cardiovascular risk factors and clinical outcomes between Western European and Southeast Asian patients treated with the Genous Bio-engineered R stent: an e-HEALING worldwide registry substudy.使用吉诺生物工程R支架治疗的西欧和东南亚患者心血管危险因素及临床结局的差异:一项全球电子健康评估与学习网络注册研究的子研究
Coron Artery Dis. 2012 Jun;23(4):271-7. doi: 10.1097/MCA.0b013e328351aaed.
2
Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry.使用健帆生物工程R支架对分叉病变患者进行冠状动脉支架置入术后的12个月临床结果:来自e-HEALING(健康内皮加速内膜化抑制新生内膜生长)注册研究。
Coron Artery Dis. 2012 May;23(3):201-7. doi: 10.1097/MCA.0b013e328351550f.
3
Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.新发冠状动脉病变高危再狭窄患者中内皮祖细胞捕获支架与 Taxus Liberté 支架的两年随访:一项随机、单中心、先导研究。
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):189-95. doi: 10.1002/ccd.23143. Epub 2011 Jul 15.
4
Duration of dual antiplatelet therapy and outcomes after coronary stenting with the Genous™ bio-engineered R stent™ in patients from the e-HEALING registry.e-HEALING 注册研究中应用 Genous™ 生物可降解雷帕霉素洗脱支架治疗患者的双联抗血小板治疗时间与临床结局
Catheter Cardiovasc Interv. 2012 Feb 1;79(2):243-52. doi: 10.1002/ccd.23156. Epub 2011 Dec 8.
5
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).西罗莫司洗脱支架、紫杉醇洗脱支架和裸金属支架置入后的临床结局(来自前瞻性多中心德国DES.DE注册研究的第一阶段)
Am J Cardiol. 2009 Nov 15;104(10):1362-9. doi: 10.1016/j.amjcard.2009.06.058. Epub 2009 Sep 26.
6
Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry).药物洗脱支架治疗保护左主干冠状动脉疾病的结果(来自多国、美国 DEScover 注册研究)。
Am J Cardiol. 2012 Feb 15;109(4):466-70. doi: 10.1016/j.amjcard.2011.09.038. Epub 2011 Nov 24.
7
Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registry.e-HEALING 注册研究中糖尿病患者应用 Genous™ 生物可降解雷帕霉素洗脱支架的 12 个月随访结果
J Interv Cardiol. 2011 Aug;24(4):285-94. doi: 10.1111/j.1540-8183.2010.00624.x. Epub 2011 Jan 31.
8
Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.对接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的患者,内皮祖细胞捕获支架与西罗莫司洗脱生物可吸收聚合物涂层支架及裸金属支架的两年临床注册随访。
J Interv Cardiol. 2010 Apr;23(2):101-8. doi: 10.1111/j.1540-8183.2010.00534.x. Epub 2010 Mar 2.
9
Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.小血管病变患者经分数血流储备指导的经皮冠状动脉血运重建术的长期临床结果。
Circ Cardiovasc Interv. 2012 Feb 1;5(1):62-8. doi: 10.1161/CIRCINTERVENTIONS.111.966937. Epub 2012 Feb 7.
10
Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.西罗莫司、他克莫司和佐他莫司洗脱支架治疗分叉病变:7个月临床结果比较
Minerva Cardioangiol. 2008 Feb;56(1):35-42.

引用本文的文献

1
Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population.亚洲人群中不同血红蛋白水平的患者接受半紧急和择期经皮冠状动脉介入治疗的临床特征及长期预后
Front Cardiovasc Med. 2022 Mar 18;9:687555. doi: 10.3389/fcvm.2022.687555. eCollection 2022.
2
12-Month clinical outcomes of amphilimus drug eluting stents in an all-comers South-East Asian registry.东南亚全人群登记研究中安普利莫司药物洗脱支架的12个月临床结局
Int J Cardiol Heart Vasc. 2020 Jan 23;26:100469. doi: 10.1016/j.ijcha.2020.100469. eCollection 2020 Feb.
3
Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes.
聚合物涂层雷帕霉素洗脱支架在欧洲和亚洲的应用:人种差异对人口统计学和临床结果的影响。
PLoS One. 2020 Jan 13;15(1):e0226606. doi: 10.1371/journal.pone.0226606. eCollection 2020.
4
9-year clinical follow-up of patients with ST-segment elevation myocardial infarction with Genous or TAXUS Liberté stents.Genous 或 TAXUS Liberté 支架治疗 ST 段抬高型心肌梗死患者的 9 年临床随访。
PLoS One. 2018 Aug 6;13(8):e0201416. doi: 10.1371/journal.pone.0201416. eCollection 2018.
5
Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts.种族对荷兰和新加坡平行冠心病队列中心血管危险因素与疾病严重程度之间的关联产生影响。
PLoS One. 2015 Jul 6;10(7):e0132278. doi: 10.1371/journal.pone.0132278. eCollection 2015.
6
Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients.荷兰和新加坡经皮冠状动脉介入治疗患者中冠状动脉疾病严重程度量化及全因死亡率的种族间差异
PLoS One. 2015 Jul 6;10(7):e0131977. doi: 10.1371/journal.pone.0131977. eCollection 2015.
7
Outcomes following percutaneous coronary intervention and coronary artery bypass grafting surgery in Chinese, South Asian and White patients with acute myocardial infarction: administrative data analysis.中文、南亚和白人急性心肌梗死患者经皮冠状动脉介入治疗和冠状动脉旁路移植术的结果:行政数据分析。
BMC Cardiovasc Disord. 2013 Dec 26;13:121. doi: 10.1186/1471-2261-13-121.